In this video, Mayo Clinic heart surgeon Dr. John Stulak discusses ventricular assist devices (VAD), including the HeartMate II and Heartware HVAD, both of which are Food and Drug Administration- approved as a bridge to support patients prior to receiving a heart transplant. VAD therapy has consistently demonstrated significant improvement in both patient survival and functional status for advanced heart failure.

свернуть